about
Improved quality of life in patients treated with Peptide radionuclides.5-Aminolevulinic acid induced fluorescence is a powerful intraoperative marker for precise histopathological grading of gliomas with non-significant contrast-enhancementEffects of norepinephrine transporter gene variants on NET binding in ADHD and healthy controls investigated by PETThe norepinephrine transporter in attention-deficit/hyperactivity disorder investigated with positron emission tomography.32nd International Austrian Winter Symposium : Zell am See, the Netherlands. 20-23 January 2016Insights into Intrinsic Brain Networks based on Graph Theory and PET in right- compared to left-sided Temporal Lobe EpilepsyEffects of Selective Serotonin Reuptake Inhibitors on Interregional Relation of Serotonin Transporter Availability in Major Depression.PET and PET/CT in endocrine tumours.Disconnective surgery in posterior quadrantic epilepsy: experience in a consecutive series of 10 patients.Monitoring of plexiform neurofibroma in children and adolescents with neurofibromatosis type 1 by [(18) F]FDG-PET imaging. Is it of value in asymptomatic patients?PET/MRI for Oncologic Brain Imaging: A Comparison of Standard MR-Based Attenuation Corrections with a Model-Based Approach for the Siemens mMR PET/MR System.Simple and rapid quantification of serotonin transporter binding using [11C]DASB bolus plus constant infusion.Association of Protein Distribution and Gene Expression Revealed by PET and Post-Mortem Quantification in the Serotonergic System of the Human Brain.Presurgical evaluation of pediatric epilepsy patients prior to hemispherotomy: the prognostic value of 18F-FDG PET.Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.Iodine-123-vascular endothelial growth factor-165 (123I-VEGF165). Biodistribution, safety and radiation dosimetry in patients with pancreatic carcinoma.Vertical perithalamic hemispherotomy: a single-center experience in 40 pediatric patients with epilepsy.Correlation of striatal dopamine transporter imaging with post mortem substantia nigra cell counts.111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.11C-methionine PET/CT imaging of 99mTc-MIBI-SPECT/CT-negative patients with primary hyperparathyroidism and previous neck surgery.NGTS-0118F-FDG PET AND PET / CT MONITORING OF PLEXIFORM NEUROFIBROMA IN CHILDREN AND ADOLESCENTS WITH NEUROFIBROMATOSIS TYPE 1.Glioma survival prediction with the combined analysis of in vivo 11C-MET-PET, ex vivo and patient features by supervised machine learning.PT550. Interregional Correlations of SERT in Attention Deficit/Hyperactivity Disorder compared to Healthy Controls; Investigated with PET and [11C]DASB.Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours.Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?Visual and semiquantitative 11C-methionine PET: An independent prognostic factor for survival of newly diagnosed and treatment naive gliomas.Quantification accuracy of neuro-oncology PET data as a function of emission scan duration in PET/MR compared to PET/CT.Bioimaging and surgery of brain tumors.Abstracts of the 33rd International Austrian Winter Symposium : Zell am See, Austria. 24-27 January 2018.Altered interregional molecular associations of the serotonin transporter in attention deficit/hyperactivity disorder assessed with PET.Progressive Dopamine Transporter Binding Loss in Autopsy-Confirmed Corticobasal Degeneration.Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.Assessing Corticospinal Tract Asymmetry in Unilateral PolymicrogyriaTowards quantitative [18F]FDG-PET/MRI of the brain: Automated MR-driven calculation of an image-derived input function for the non-invasive determination of cerebral glucose metabolic ratesMolar activity - The keystone in C-radiochemistry: An explorative study using the gas phase methodDopamine D2 receptor SPECT in corticobasal syndrome and autopsy-confirmed corticobasal degenerationMultiparametric PET imaging in thyroid malignancy characterizing tumour heterogeneity: somatostatin receptors and glucose metabolismCoronary Vasoreactivity in Subjects with Thyroid Autoimmunity and Subclinical Hypothyroidism Before and After Supplementation with Thyroxine90Y-ibritumomab tiuxetan (Zevalin) in heavily pretreated patients with mucosa associated lymphoid tissue lymphoma
P50
Q33398609-BC12913E-3A5D-4DB3-844A-AF96374E9BCBQ35034931-50DA5F4A-CB5C-4707-94B2-BFD68FD06376Q35871702-2E6EE23F-AB0B-4336-9839-C7E16C7AB578Q36424492-3468939C-55D1-4288-A15A-FEFDABC9BCA6Q36809104-EA297117-48CD-4328-AD12-A42083602FC2Q37044466-A10D9F3F-2ABA-4765-9000-98373FACEE4DQ37625437-400B34B0-F99D-4F51-8E93-DBADCF76FDEAQ37678687-55DAFD27-4ECD-4056-B6D5-370093752890Q38110857-93AA061E-12DC-43A8-BA78-8919FFE2CEA9Q38644016-5E7F4E29-4FDE-4A34-9B42-10C0B9B1572AQ38932293-945BB81B-3968-43E1-B2C4-1897BE64A821Q39001294-5AA9D8A6-70E3-4971-BFD0-2CC02E31A242Q39138127-C0B4AE41-28BF-46AE-A912-4BC66C7C3E1CQ39406697-0D504DD8-5941-404A-9E0B-B4B6B1D837D3Q40346377-FB8EA3F3-576E-4D29-BFD7-454A4DD8524DQ40501033-6FAE55E4-1E94-4594-B222-0D4DC39A22BAQ42622807-5872B903-46AE-4E31-B293-9E606B6C67CAQ43526336-1357C683-55B1-4D39-8B91-7F0D401CDB99Q44455050-0CF8422A-7D6B-4BDB-85CF-C0FFC78AC0B4Q45420411-0D39EF48-9508-4668-AB97-4C3A6F0607ECQ45834215-58B4CC25-BABC-4DE3-9059-F744FE38A743Q45943604-9AAC1F3C-5842-416E-90EE-EA50861DCC6CQ46196480-7F64270F-7739-4509-9AC8-441D12E36529Q46954898-B75ECEBE-A06C-464A-8E4F-7A2A7F5181B3Q47172800-BF974DE5-0C2E-4F0D-BF69-A743EBE3A654Q47583631-419473FF-B2BD-4B70-BC6C-94F9C4CFE3F3Q47592398-7A234DBA-F8CC-4328-9BFE-BD88ADAEC58BQ47846223-ECE18ED7-1AC8-4807-BF18-A5AEB57BA048Q48513004-78CF8339-3574-45A9-AB9E-D9A1FB2F2D28Q52117145-BBF6B4B6-F1E3-4A7E-90D6-28CB3CA03DF5Q52147728-33699307-794C-4718-AFC6-987B7F49DE54Q53264488-F882E3A5-5940-4B52-A90F-1B0D0E897574Q53308898-18D8AFF7-1025-4C40-8381-3851672FEFB5Q56232618-5E9BE753-CB74-4E15-B386-102CD3E9AB79Q57721203-BD59F5C9-0EBC-4771-BA16-25207B7C090FQ58122829-9B9FD60C-065E-4D77-A4AE-24711CE06A7BQ60699272-C7D6B196-E514-492B-AB17-C9A18FA8035AQ62863996-11F0BB91-3DE9-41B1-B526-097486C884EEQ62864026-0D105923-6574-4DEA-9088-D3FBB68FF0AEQ62864038-1B1B9A39-2F04-4482-8DCA-45097F381CE2
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-1118-926X
@en
name
T Traub-Weidinger
@ast
T Traub-Weidinger
@en
T Traub-Weidinger
@nl
type
label
T Traub-Weidinger
@ast
T Traub-Weidinger
@en
T Traub-Weidinger
@nl
altLabel
Tatjana Traub-Weidinger
@en
prefLabel
T Traub-Weidinger
@ast
T Traub-Weidinger
@en
T Traub-Weidinger
@nl
P106
P31
P496
0000-0003-1118-926X